EquityZen Growth Technology Fund LLC - Series 1324
Raised
$413K
Investors
23
Min Invest
$9,990
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1324 is a Delaware-domiciled pooled investment vehicle filed by EquityZen Advisors LLC that raised $413K from 23 investors under Rule 506(b) and Section 3(c)(1) exemptions. The fund requires a $10K minimum investment and is part of EquityZen's pre-IPO secondary marketplace platform, which operates nearly 1,900 series-specific SPVs accessing private company equity.
This pre-IPO fund follows the standard EquityZen platform model: a 506(b) private placement combined with 3(c)(1) Investment Company Act exemption, targeting retail-accessible minimums ($10K). The capital raise and investor count are consistent with single-company exposure SPVs common in secondary pre-IPO marketplaces, where each series typically targets shares of one private growth company.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
